Citigroup’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.1M | Sell |
115,200
-44,800
| -28% | -$6.27M | 0.01% | 1196 |
|
|
2025
Q4 | $19.6M | Hold |
160,000
| – | – | 0.01% | 1120 |
|
|
2025
Q3 | $17.8M | Buy |
160,000
+1,800
| +1% | +$205K | 0.01% | 1136 |
|
|
2025
Q2 | $17.5M | Sell |
158,200
-24,000
| -13% | -$2.55M | 0.01% | 1038 |
|
|
2025
Q1 | $20.4M | Sell |
182,200
-109,500
| -38% | -$11.3M | 0.01% | 961 |
|
|
2024
Q4 | $26.9M | Buy |
291,700
+100,000
| +52% | +$9M | 0.02% | 798 |
|
|
2024
Q3 | $16.1M | Sell |
191,700
-72,200
| -27% | -$5.51M | 0.01% | 1059 |
|
|
2024
Q2 | $18.1M | Buy |
263,900
+107,400
| +69% | +$7.17M | 0.01% | 934 |
|
|
2024
Q1 | $11.5M | Sell |
156,500
-218,000
| -58% | -$16.8M | 0.01% | 1174 |
|
|
2023
Q4 | $30.3M | Sell |
374,500
-100,000
| -21% | -$7.78M | 0.02% | 662 |
|
|
2023
Q3 | $35.6M | Buy |
474,500
+237,000
| +100% | +$18.2M | 0.03% | 550 |
|
|
2023
Q2 | $18.3M | Buy |
237,500
+30,000
| +14% | +$2.39M | 0.01% | 864 |
|
|
2023
Q1 | $17.2M | Sell |
207,500
-501,500
| -71% | -$41.5M | 0.01% | 891 |
|
|
2022
Q4 | $60.9M | Sell |
709,000
-150,000
| -17% | -$11.9M | 0.05% | 348 |
|
|
2022
Q3 | $53M | Buy |
859,000
+62,500
| +8% | +$3.94M | 0.04% | 357 |
|
|
2022
Q2 | $49.2M | Sell |
796,500
-377,500
| -32% | -$23.4M | 0.04% | 391 |
|
|
2022
Q1 | $69.8M | Sell |
1,174,000
-480,000
| -29% | -$30.7M | 0.04% | 374 |
|
|
2021
Q4 | $120M | Buy |
1,654,000
+1,045,000
| +172% | +$72M | 0.06% | 270 |
|
|
2021
Q3 | $42.5M | Buy |
609,000
+150,000
| +33% | +$10.5M | 0.03% | 608 |
|
|
2021
Q2 | $31.6M | Sell |
459,000
-411,000
| -47% | -$27.4M | 0.02% | 752 |
|
|
2021
Q1 | $56.2M | Sell |
870,000
-250,800
| -22% | -$16.2M | 0.04% | 454 |
|
|
2020
Q4 | $65.3M | Buy |
1,120,800
+271,200
| +32% | +$16.4M | 0.04% | 423 |
|
|
2020
Q3 | $53.7M | Buy |
849,600
+48,300
| +6% | +$3.35M | 0.04% | 421 |
|
|
2020
Q2 | $61.7M | Sell |
801,300
-548,700
| -41% | -$42.1M | 0.05% | 342 |
|
|
2020
Q1 | $101M | Buy |
1,350,000
+329,100
| +32% | +$22.7M | 0.09% | 185 |
|
|
2019
Q4 | $66.3M | Buy |
1,020,900
+283,300
| +38% | +$18.4M | 0.05% | 377 |
|
|
2019
Q3 | $46.7M | Sell |
737,600
-31,000
| -4% | -$2.03M | 0.04% | 488 |
|
|
2019
Q2 | $51.9M | Sell |
768,600
-66,300
| -8% | -$4.36M | 0.04% | 427 |
|
|
2019
Q1 | $54.3M | Sell |
834,900
-187,900
| -18% | -$12.5M | 0.05% | 370 |
|
|
2018
Q4 | $64M | Sell |
1,022,800
-121,700
| -11% | -$8.51M | 0.06% | 302 |
|
|
2018
Q3 | $88.4M | Sell |
1,144,500
-123,400
| -10% | -$9.32M | 0.08% | 219 |
|
|
2018
Q2 | $89.8M | Sell |
1,267,900
-13,500
| -1% | -$953K | 0.08% | 193 |
|
|
2018
Q1 | $96.6M | Buy |
1,281,400
+119,800
| +10% | +$9.52M | 0.08% | 208 |
|
|
2017
Q4 | $83.2M | Buy |
1,161,600
+71,600
| +7% | +$5.44M | 0.07% | 261 |
|
|
2017
Q3 | $88.3M | Buy |
1,090,000
+275,900
| +34% | +$21.1M | 0.07% | 227 |
|
|
2017
Q2 | $57.6M | Sell |
814,100
-520,600
| -39% | -$34.6M | 0.05% | 296 |
|
|
2017
Q1 | $90.7M | Buy |
1,334,700
+615,800
| +86% | +$43.3M | 0.08% | 204 |
|
|
2016
Q4 | $51.5M | Sell |
718,900
-385,800
| -35% | -$28.7M | 0.05% | 378 |
|
|
2016
Q3 | $87.4M | Buy |
1,104,700
+229,800
| +26% | +$18.7M | 0.08% | 218 |
|
|
2016
Q2 | $73M | Buy |
874,900
+213,400
| +32% | +$18.9M | 0.07% | 246 |
|
|
2016
Q1 | $60.8M | Sell |
661,500
-1,231,200
| -65% | -$111M | 0.07% | 262 |
|
|
2015
Q4 | $192M | Buy |
1,892,700
+484,700
| +34% | +$50.4M | 0.19% | 83 |
|
|
2015
Q3 | $138M | Sell |
1,408,000
-568,800
| -29% | -$63.2M | 0.13% | 116 |
|
|
2015
Q2 | $231M | Sell |
1,976,800
-340,200
| -15% | -$37.2M | 0.21% | 59 |
|
|
2015
Q1 | $227M | Sell |
2,317,000
-428,100
| -16% | -$43.5M | 0.22% | 61 |
|
|
2014
Q4 | $259M | Buy |
2,745,100
+239,900
| +10% | +$24.8M | 0.23% | 56 |
|
|
2014
Q3 | $267M | Buy |
2,505,200
+125,600
| +5% | +$12.3M | 0.23% | 48 |
|
|
2014
Q2 | $197M | Sell |
2,379,600
-333,000
| -12% | -$25.9M | 0.19% | 73 |
|
|
2014
Q1 | $192M | Sell |
2,712,600
-490,700
| -15% | -$38.5M | 0.2% | 71 |
|
|
2013
Q4 | $241M | Buy |
3,203,300
+833,000
| +35% | +$58M | 0.22% | 65 |
|
|
2013
Q3 | $149M | Buy |
2,370,300
+457,100
| +24% | +$27.3M | 0.14% | 113 |
|
|
2013
Q2 | $98M | Buy |
+1,913,200
| New | +$99.7M | 0.1% | 155 |
|
Other funds holding GILD
VCM
VPM
Citigroup's GILD Position: Q1 2026 in Review
Citigroup increased its Gilead Sciences (GILD) stake by 30% in Q1 2026, buying an estimated $73.4M and bringing the position to 2,300,271 shares worth $321M. The position accounts for 0.14% of the portfolio, ranked #145.
Citigroup first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Citigroup held 2,300,271 shares of Gilead Sciences worth $321M as of Q1 2026.
- Citigroup bought 524,041 Gilead Sciences shares in Q1 2026, an estimated $73.4M.
- Gilead Sciences made up 0.14% of Citigroup's portfolio in Q1 2026, its #145 holding.
- Citigroup first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.